No Data
bluestar adisseo (600299) performance review for the third quarter of 2024: Strong sales of methionine, significant increase in performance quarter-on-quarter and year-on-year.
Event: On October 30, 2024, Bluestar Adisseo announced its third quarter report of 2024: the company achieved a revenue of 11.376 billion yuan in the first three quarters of 2024, an increase of 18.32% year-on-year; achieving a net income attributable to the parent of 1
Revenue Beat: Bluestar Adisseo Company Beat Analyst Estimates By 5.5%
Bluestar Adisseo Falls to Q3 Loss, Revenue Up 25%
Andisu 2024 Third Quarter Report
ANDISU Announces Key Operating Data for the Third Quarter of 2024
Bluestar Adisseo (600299.SH): The net income for the first three quarters is approximately 1.003 billion yuan.
Glorycrops reported on October 29th that Bluestar Adisseo (600299.SH) announced that its revenue in the first three quarters of 2024 was approximately 11.376 billion yuan, an increase of 18.32% year-on-year; net income attributable to shareholders of listed companies was approximately 1.003 billion yuan; basic earnings per share was 0.37 yuan.
No Data
No Data